Risk of Positive Doping Tests Following Ingestion of Supplements Contaminated With Trace Quantities of Nandrolone Metabolites
Launched by LOUGHBOROUGH UNIVERSITY · May 20, 2008
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy male and female volunteers aged between 18 - 35 years of age
- Exclusion Criteria:
- • Any potential participant competing in sport at a level where there is even a remote possibility of being called for a drugs test was excluded
About Loughborough University
Loughborough University is a leading UK higher education institution renowned for its commitment to research excellence and innovation in various fields, including health and sports sciences. As a clinical trial sponsor, the university leverages its extensive expertise and state-of-the-art facilities to design and conduct robust clinical studies aimed at advancing medical knowledge and improving patient outcomes. With a focus on interdisciplinary collaboration, Loughborough University fosters partnerships with industry and healthcare organizations, ensuring that its research initiatives are both impactful and aligned with real-world health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Loughborough, Leicestershire, United Kingdom
Patients applied
Trial Officials
Ronald Maughan, PhD
Principal Investigator
Loughborough University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials